Expert insights

GYNECOLOGY

Lichen Sclerosus | Vaginal Dryness

Dr Vanessa Rabeau-Conri

Expert insightsGYNECOLOGY

Dr. Vanessa Rabeau-Conri

Gynecologic Oncologic Surgeon
President, VIVMED

“Quality of life is an integral part of care.”
Why is it important to address women's intimate health?

Because it has long been considered a secondary concern. Vaginal dryness, burning sensations, vulvar pain, painful or impossible intercourse, and urinary leakage affect the majority of women at some point in their lives, yet many never discuss these issues with a healthcare professional.

These symptoms are neither an inevitable consequence of aging nor merely a matter of comfort. They can have a significant impact on sleep, relationships, self-confidence, and professional life.

In oncology, I see women every week who have been cured of cancer but are left to cope alone with the intimate consequences of their treatments. Addressing intimate health means recognizing that quality of life is an integral part of patient care.

For which conditions is regenerative medicine suitable to help relieve symptoms in female patients?

Regenerative medicine has a role as an adjunct to standard-of-care treatments, in carefully selected indications and following a comprehensive clinical evaluation.

With autologous PRP, the primary indications include the atrophic and scarring sequelae of chronic vulvar dermatoses such as lichen sclerosus, once inflammation is under control; painful pelvic and perineal scars or adhesions following surgery or childbirth; and mild stress urinary incontinence in appropriately assessed patients who have already undergone pelvic floor rehabilitation.

In genitourinary syndrome of menopause (GSM), PRP may be considered as an option for women who cannot or do not wish to use local hormonal therapies, with the understanding that clinical evidence is still evolving and continues to be strengthened.

What has been your experience with RegenLab solutions?

I use RegenLab kits at VIVMED Bordeaux and VIVMED Biarritz for the preparation of autologous PRP. What drove this choice was standardization: a reproducible, closed-system preparation protocol that delivers a consistently high-quality product from one patient to another. This is essential in a field where we aim to evaluate outcomes rigorously.

The combination of PRP and hyaluronic acid is also particularly interesting in indications where both a trophic effect and structural tissue support are desired, especially for scars and fibrotic adhesions.

The procedure is straightforward, well tolerated, and integrates seamlessly into our care pathway alongside rehabilitation, psycho-sexual support, and photobiomodulation.

The benefits observed in terms of tissue flexibility, pain reduction, and overall comfort are significant in some patients, more variable in others, and consistently greater when the injections are part of a comprehensive, multidisciplinary treatment approach.

What message would you like to share with women?

You do not have to resign yourself to living with it. Persistent intimate discomfort is neither normal nor something to be ashamed of, and solutions do exist, even when conventional treatments are not an option.

The first step is often the hardest: talking about it. Choose a healthcare professional with expertise in these conditions, ask all your questions, and make sure you are given clear information about what has been scientifically demonstrated and what is still being investigated.

Your intimate health deserves the same level of care and attention as every other aspect of your health.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

RegenWound

RegenWound is a fully autologous solution prepared from the patient’s own blood, with the objective of providing a standardised and reproducible approach for clinical use.

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EU-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.